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ABSTRACT
Background: Vaso-occlusive (VOC) pain crisis in sickle cell pediatric patients is a hallmark
symptom, and both unpredictable and crippling. There is a lack of evidence as to what is best
practice to avoid a VOC pain crisis in pediatric sickle cell patients. Individualized Pain Plans
were created and trialed based off the format asthma action plans with goals to improve overall
pain management and to prevent or decrease emergency department visits and hospitalizations.
Aims: This is a cross-sectional and quality improvement study designed to evaluate the
effectiveness of previously implemented Individualized Sickle Cell Pain Plans in a midwestern
children’s hospital. The primary aim was to evaluate the physical and psychosocial risk factors
related to the pain experiences in the post implementation timeline of receiving their
individualized pain plan. The second aim was to evaluate the satisfaction and use by both parent
and child of the pain plans.
Methods: Evaluation of outcomes of these plans were done by survey using the Pediatric Pain
Screening Tool (PPST), satisfaction questionnaires, and chart audits of Emergency Department
(ED) visits due to pain crisis pre and post implementation administered by the
Hematology/Oncology (H/O) team.
Settings: This study was conducted at a midwestern children’s hospital and associated H/O
clinic.
Participants/Subjects: Sample population included pediatric patients, aged four to 18 years old,
who are diagnosed with sickle cell disease who have an individualized pain plan created by their
Hematology provider, and their parent(s) and/or caregivers. Each patient/parent/caregiver
gave verbal consent to participate.
Design: The data was collected at a routine follow up appointment at the H/O clinic. Surveys
were administered at the appointments including the PPST, demographics, and a satisfaction/use
survey for the patient and parent. A chart audit of ED visits due to pain crisis pre and post pain
plan implementation was also performed.
Results: A total of eleven patients and eleven parents were captured in this study that qualified
based on the inclusion criteria. 73% of responses being mostly satisfied and very satisfied with
the pain plans, 27% of responses were sometimes satisfied and satisfied, and one response with
no satisfaction. Eleven parents were asked how often the pain plans were being used and/or
referenced, 18% said they were not using it and needed help with how to use it better, 9% use it
when their child cannot sleep at night due to pain, 45% use it when their child cannot play or go
to school due to pain, and 27% said they use it when their child tells them they have pain. Six
patients were then asked how often they were using the pain plans, one said they do not use it
because he lost it, one said they do not know how to use the pain plan, one said they use it when
they cannot play, and three (50%) say they use it when an adult tells them to. We compared the
number of ED and inpatient hospital admissions (IHA) for each patient pre and post pain plan
implementation and found that ED visits decreased from pre (29 of 74 patients) to post (16 of 74
patients).
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Conclusions: Individualized pain plans provide guidance for patients and families when a pain
crisis begins. It is recommended that these pain plans be implemented at other pediatric hospitals
across the nation to support patients with sickle cell disease and their families. It would be
recommended that the clinic continue to collect data indefinitely due to the small sample
population of this study as this could provide stronger evidence for the use of the individualized
pain plans.
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It is estimated that approximately 100,000 Americans (including infants) are burdened by
sickle cell disease (SCD). Specific populations demonstrate different rates of occurrence of SCD,
including one out of every 365 Black or African American births. One in every 13 Black or
African American babies and one out of 16,300 Hispanic American births are born with the
sickle cell trait. (Data & Statistics on Sickle Cell Disease 2020). 9% of children in Nebraska with
SCD have at least one crisis per year. (Abughanimeh et al., 2020) Pediatric patients with SCD
experience symptoms related to the condition including anemia, acute chest syndrome, frequent
infections, activity intolerance, and the hallmark symptom of vaso-occlusive pain crisis (VOC).
The VOC is both unpredictable and crippling. SCD is inherited with an autosomal recessive
pattern; with this condition, the child does not form the normal hemoglobin A molecule but a
synthesized Hemoglobin S (Hgb S). Hgb S causes the shape of the red blood cell to “sickle” and
leads to chronic hemolytic anemia. This sickled shape is rigid and clogs small blood vessels
leading to ischemia, pain, and other vaso-occlusive problems. (Maaks, et al., 2020)
Significance
As a child grows older, these VOC episodes become more frequent and more painful
(Panepinto, et al., 2005). Due to variations of disease pathophysiology, comorbidities, and
individual/family health behaviors, children diagnosed with SCD face many obstacles
throughout their life. This disease secondarily creates emotional stress, school absenteeism
associated with academic problems, financial strain on the family, and an ongoing need to access
health care. Many of these patients and families feel as if this disease completely controls their
lives. The experiences of pain associated with VOC and other chronic symptoms of SCD have a
negative impact on the health-related quality of life (HRQoL) of the child and family (Brandow
et al., 2020)
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Literature Review
Chronic pain in youth with sickle cell disease is not as clearly defined as it is for adults
with SCD (Sil et al., 2016). A recent study described that 23% (N =100) of a population of youth
(eight to 18 years of age) with SCD had chronic SCD pain. Chronic pain in the adult population
is defined as pain more than three days per week for more than three months (Sil et al., 2016).
This study suggests the percentage of youth with chronic pain is similar to the adult SCD
population (29% incidence), however additional studies are needed to better define chronic pain
in youth with SCD (Sil et al., 2016). Chronic sickle cell pain has been characterized by pain
catastrophizing, depression, functional impairment, and increased pain perception that leads to
potentially greater difficulty in managing pain (Goldstein-Leever et al., 2018). Individuals with
chronic sickle cell pain are more likely to have more frequent hospital and ED admissions for
pain management.
While only three studies (Improving Care for Sickle Cell Pain Crisis Using a
Multidisciplinary Approach, by Balsamo et al. (2019), Using quality improvement methods to
implement an electronic medical record (EMR) supported individualized home pain management
plan for children with sickle cell disease by Crosby et al. (2014); and Impact of individualized
pain plan on the emergency management of children with sickle cell disease by Krishnamurti et
al. (2014) were found that demonstrated specific evidence for the home use of individualized
pain plans for pediatric patients with SCD and advocated for their use. Although these
publications acknowledged these individualized pain plans to be advantageous, no, or limited
data or evidence was brought forth to support the claim. While limited, the data gathered from
the three studies demonstrated evidence for the efficacy of individualized pain plans for home
use: with each documenting a decrease in ED (emergency department) visits, admission rates,

6
readmission rates, and/or length of stay. There is a gap in the knowledge of how individualized
self-care plans implemented in the home can lead to a decrease in symptoms such as pain,
promote satisfaction with self-care, and reduce the number of admissions and clinic visits related
to pain. This study will fill this gap by assessing the pain experience and satisfaction of the use
of an individualized pain plan in a population of children diagnosed with SCD and their
families.
A retroactive study was done in Nebraska looking at the number of sickle cell patients
who had care at two biggest tertiary care centers in the state: one large adult health care setting
and a pediatric health care setting, 358 patient charts were retrospectively reviewed from January
2014 to 2020. A total of 358 patients were reviewed with 355 patients included in the study.
Ninety-six of them were adults with SCD (mean age of 28.9 years) while 82 were children with
SCD (mean age 5.7 years), and 178 patients with sickle cell trait. (Abughanimeh et al., 2020)
Purpose
The purpose of this project is to evaluate the effectiveness of individualized pain plans
(see Figure 1) for a population of children diagnosed with SCD and their families. Primary aims
will focus on the evaluation of 1) the physical and psychosocial risk factors related to the pain
experiences following the implementation of the individualized pain plan. The secondary aims
include evaluation of 1) the parent and child’s satisfaction with use of the plan at home; and 2)
the number of child admissions to the ED, infusion center, and hospital for a SCD pain crisis.
The risk factor score, satisfaction, and readmission documentation will be utilized to assist in the
evaluation of the individualized pain plans and determine the need for the H/O clinic team to
provide additional education, support, or adjust the individualized pain plan.
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The home-based pain plan was established by the child’s H/O physician and
individualized for each child to focus on home pain management. The plan design used the
green, yellow, and red concepts of the Asthma Action Plan. (Asthma and Allergy Foundation of
America, 2015) The green zone occurs when pain is rated as a zero, one, or two on the zero to 10
pain scale. During this time in the green zone the child can do daily activities and has a
medication assigned to use for minimal pain. The green zone includes as needed (non-opioid)
pain medication(s) including Tylenol and/or Ibuprofen. The yellow zone occurs when pain is
rated as three through seven. The yellow zone is described when the child is having trouble
keeping up with others due to the pain experience, therefore, one or two medications are
assigned for mild to moderate pain. The yellow zone includes scheduled (non-opioid) pain
medication because the child is in pain, with potential for taking an as needed opioid medication,
though not all kids will have this option, specifically younger kids who do not have opioids at
home. If a child requires more than 3 doses of an opioid medication to treat their pain, they need
to call the H/O clinic. The red zone occurs when the pain is rated as an eight, nine or 10 and is
severe and the child and family are unable to control the pain at home. Children/families that
experience the red zone should go to the ED or call the clinic. These plans were created to
increase self-care knowledge for pain management, specifically for children diagnosed with SCD
and their families. It is also important to evaluate if these pain self-care action plans lead to a
reduction in the number of clinic visits, ED visits, and hospital admissions related to Vasoocclusive pain crisis.
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Figure 1: Sample Individualized Home Pain Plan

J. Beck, L. Leyden, and A. Whitman personal communication related to individual self-care pain
action plan template on August 15, 2020.
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Theoretical Frameworks
The Framework Model for Improvement will be used as the conceptual model for this
study. The focus of this conceptual framework is the Plan, Do, Study, Act (PSDA) model to test
the change that the pain plan is implementing to improve the quality of the current policy. This is
a scientific method used for action-oriented learning and testing a change by: planning, trialing,
measuring/studying the data/results, and acting on what is learned. (Science of Improvement:
Testing Changes: IHI 2021) The PDSA systematic quality improvement process has
demonstrated success in establishing iterative changes in improving sickle cell pain (Sil et al.,
2018).
The first step in the cycle is to develop a “Plan” that includes establishing the test or
observation, including how to collect data. This project plan is to evaluate the H/O team’s
individualized pain plan, with a focus on the effectiveness and satisfaction in the use of the
individualized pain plan designed for each patient diagnosed with SCD. Data collection will be
done through the administration of two short questionnaire surveys administered to a
convenience sample of children/parents/legal guardians who have implemented their
individualized pain plan during the past six to 12 months. The Pediatric Pain Screening Tool
(PPST) (Sil et al., 2018; Simons et al., 2015) and child and parent satisfaction surveys will be
administered during a routine visit to the H/O clinic. Additional data collection will also be
initiated through an electronic health record chart review, focusing on admissions to the: ED,
Infusion Center, H/O clinic visits, and hospital admissions for sickle cell pain.
The second step is the “Do” cycle in which the focus is to carry out the test while
documenting problems and observations. This part of the project will involve the active data
collection and recording of survey responses from the questionnaires and chart audits of
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consenting/assenting subjects. Children/parents/legal guardians who have utilized their
individualized pain plan for six to nine months or 12 to 15 months will complete the Pediatric
Pain Screening Tool (PPST, see Figure 2) (Sil et al., 2018; Simons et al., 2015) and the
satisfaction surveys. The DNP (Doctor of Nursing Practice) team will audit medical record chart
data for admissions to the ED, infusion center, and hospital six months prior to receipt of the
pain plan for each participant and for the most recent six-month time period for participants who
have implemented their pain plans for six through nine months or 12 to 15 months.
In the “Study” phase the team will analyze, summarize, and examine the data collected
from the survey responses and the chart review. This team and the H/O team who care for and
treat the pediatric SCD patients met and discussed these results.
The fourth and last step is the “Act” cycle will assist in determining what modifications
need to be made to the pain plans based on survey results. The H/O team will continue to meet
with the patients and families to reinforce learning (based on the outcomes), provide additional
resources, and offer support related to their physical and psychosocial risk.
Methods
Design
The process for data collection began with distributing the PPST (Sil et al., 2018; Simon
et al., 2015) and satisfaction questionnaire to assenting/consenting children/families who
presented to a Midwest children's H/O clinic for sickle cell disease follow-up appointments. Data
collection also included a chart audit of all enrolled subjects and assess the pre- and postimplementation data related to admission to the clinic, ED, infusion center, or hospital for pain
crises. This project will compare PPST (Sil et al., 2018; Simon et al., 2015) risk category (low,
medium, or high), satisfaction information from the parent and child, and audit data related to
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admissions for pain (pre- and post-implementation of the pain plans) to establish the
effectiveness, satisfaction, and identified needs for improvement with the implementation of the
individualized pain plan.
Setting and Sample
This project occurred at a children’s hospital and clinic in the Midwest. Departments
involved in the project included the H/O clinic, ED, hospital, infusion center, and electronic
medical records.
Research participants will include children diagnosed with sickle cell disease and their
caregivers/parents/legal guardians who have received education and who have implemented their
individualized pain plan. The ages of the child participants will range from four to 18 years of
age. The convenience sample will consist of children from two groups who have implemented
their plans within two time periods including six to nine months and 12 to 15 months.
The inclusion criteria include: the pediatric population of four to 18 years old, a diagnosis
of sickle cell disease at the hospital, and implementation of the individualization pain plan for six
to nine months or 12 to 15 months. The exclusion criteria included other comorbidities that do
not allow a pain plan to be administered, and developmental/psychological inability to answer
questions on their own behalf, and children/families who have not implemented or received their
pain plan from the H/O clinic within the two established time periods.
The number of patients included in this project will be based upon those who have
completed their pain plan education and have utilized the plan at home for two designated time
periods. Currently, the H/O team has 120 patients under their care. The rollout for each of these
pain self-care action plans began in August of 2020 and remains ongoing. Based on the number
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of individualized pain plans that had been implemented, it was established that a goal of
approximately 25-30 children would have been eligible to participate in this study.
Interventions
The intervention of this project is an evaluation approach of the Sickle Cell Pain Plans
created by the stakeholders of whom are providers in the clinic. To evaluate the use,
effectiveness, and satisfaction of the pain plans, in-person paper surveys were completed that
included demographics, satisfaction questionnaires, and the PPST. A chart audit was also
performed to assess differences of ED admission rates related to pre and post implementation of
the Sickle Cell Pain Plans.
Pain and Risk Screening Tool
The team researched methods to evaluate pediatric pain that have validity and discovered
the PPST. This is described as a self-report tool that is used to measure the risk status of poor
pain related outcomes in children (Sil et al., 2019; Simons et al., 2015). This tool was designed
by the Stanford Biobehavioral Pediatric Pain Lab and permission for use was obtained. The
American Pain Society Pain Taxonomy (AAPT) has defined chronic SCD pain as pain
experienced greater than 15 days (about 2 weeks) a month for at least six months (Dampier, et
al., 2017). Findings identified both the sensitivity and specificity for the PPST (related to chronic
pain) ranged from adequate to excellent, with regards to significant disability (78%, 68%) and
high emotional distress (81%, 63%) (Simons et al., 2015). One study focused specifically on a
population of children diagnosed with SCD described the high-risk pediatric group to have a pain
and psychosocial profile consistent with chronic SCD pain, which acknowledges that the PPST
may be useful for efficiently identifying youth with chronic SCD pain or those at risk of poor
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outcomes (Sil et al., 2018). This risk assessment will provide knowledge for the H/O team
related to the need for additional intervention and support of each child/family.
The PPST (Sil et al, 2018; Simons et al, 2015) tool consists of nine brief questions that
assess both physical and psychosocial pain risk subscales related to the child’s life experience
during the two weeks prior to tool administration. The pain experience items assessed in the
physical subscale include comorbid pain, ambulating, attending school, and sleep. The pain
experience items assessed in the physical subscale include comorbid pain, ambulation, school
attendance, and sleep quality. The items assessed in the psychosocial risk subscale include pain
catastrophizing, pain-related fear, general anxiety, depression, and pain aggravation. Eight of the
nine survey questions are answered with “agree” (one point) or “disagree” (zero point). The final
item on the survey evaluates how much pain has been a problem in the last two weeks with a
response on a scale from “not at all” to “a whole lot.” Scoring of this survey is based on the total
score and score of the psychosocial subscale. Scores rated using the terms “a lot” and “a whole
lot” are equal to one point; lower ratings from “not at all” to “some” are scored as a zero (Simons
et al., 2015).
The scoring of this survey is based on a total score from zero to nine. The physical
subscale scores range from zero to four and the psychosocial subscale range from zero to five.
Low risk is a total score of less than or equal to two; Medium risk described as a total score of
greater than or equal to three and psychosocial subscale score of less than or equal to two; High
risk is described as total scores of greater or equal to three and a psychosocial subscale score of
greater than or equal to 3 (Sil et al., 2019; Simons et al., 2015). Children identified in the lowrisk category are more responsive to education (such as the pain plan). Children identified in the
medium risk group may be transitioning from acute to chronic pain experiences, therefore this
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category suggests the child may require additional education (with application of the pain selfcare action plan) and assistance with coping (Sil et al., 2019). Children identified in the high-risk
category require more biopsychosocial services (in addition to need for greater educational
support with the use of the pain plan) to include additional interdisciplinary services (Sil et al.,
2019). The PPST will be used in correlation to discover if pain management is better controlled
the longer the child has utilized the Sickle Cell Pain Plan has been provided to them.

Figure 2: Pediatric Pain Screening Tool
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Pain and Self-Care Satisfaction Survey
In addition, children diagnosed with SCD, and their caregiver/parent/legal guardian will
describe their satisfaction with use of the individualized pain plan through a separate survey
provided by the data collection team. It was administered to assess the satisfaction with the
implementation of the individualized pain plan. The focus of the two surveys was on the
perceptions of the child and their parent/guardian after the implementation of the use of the
individualized pain plan at home. The focus of the qualitative satisfaction survey
questions allowed the H/O clinic team to offer additional support and education with the
child/parent(s), guardian in the application of the plan. In addition, this information may suggest
modification of methods of education delivery or further individualization of the pain plan.
Chart Audit
A chart audit was completed to evaluate pain crisis admissions to the ED, infusion center,
hospital, and H/O clinic. These audits were completed retrospectively for the 6-month period that
occurred prior to the implementation of the individualized pain plan. A second chart audit was
completed after each child/parent/legal guardian had utilized the individualized pain plan for
either six to nine months or for 12 to 15 months. The post-implementation audit was completed
in the most recent 6-month time- period.
Measures
The authors of this paper chose to evaluate both qualitative and quantitative data to best
measure the efficacy of the sickle cell individualized pain plans. The qualitative data was
gathered utilizing in-person survey collection means and included patient demographics,
caregiver/parent/legal guardian satisfaction, patient satisfaction, and the PPST. The PPST is a
self-report tool that provides assessment of pain and psychosocial risk status for poor outcomes
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associated with chronic sickle cell pain in youth (Sil et al., 2020; Simons et al., 2015). This tool
promotes pain assessment focused on both physical and psychosocial impact that can identify the
need for additional educational interventions and/or support. It was chosen for this study due to
its reliability and validity as well as its ease of use and cost. Taking these factors into
consideration, it was deemed an appropriate tool for long-term use by the H/O clinic providers.
The demographics and satisfaction surveys were analyzed using the Flesch Kincaid
Grade Level indicator for readability and deemed appropriate for third to fourth graders. The
satisfaction surveys were limited to four questions: two multiple choice and two fill in the blank.
While the surveys are short and simple, they encompass the main questions that the H/O clinic
providers felt should be evaluated. They include the following:
·

How satisfied are you with your pain plan?

·

How often do you (or your child) use the pain plan?

·

What is one thing about the pain plan that helps your (or child’s) pain?

·

What is one thing about the pain plan that does not help your (or child’s) pain?

Ethical Considerations
As the sickle cell population is predominantly African American and Hispanic, the
surveys were available with the use of an interpreter if indicated. The surveys were also analyzed
using the Flesch Kincaid Grade Level indicator for readability and deemed appropriate for third
to fourth grade reading levels. There are no potential conflicts of interest within this study or any
disclosures.
Results
Of the total number of sickle cell patients, N = 175, the number of patients enrolled in
pain plans was n=74. These patients had pain plan enrollment dates ranging from 08/03/2020 to
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02/29/2022. A total of eleven patients and eleven parents were captured in this study that
qualified based on inclusion criteria. Eleven parents responded to the satisfaction survey, with
73% of responses being mostly satisfied and very satisfied with the pain plans, and 27% of
responses saying: sometimes satisfied (it helps for a few hours) and satisfied (it helps for part of
the day) and one response with no satisfaction. Eleven parents were asked how often the pain
plans were being used and/or referenced, 18% said they were not using it and needed help with
how to use it better, 9% use it when their child cannot sleep at night due to pain, 45% use it when
their child cannot play or go to school due to pain, and 27% said they use it when their child tells
them they have pain. Six patients were then asked how often they were using the pain plans, one
said they do not use it because it was lost, one said they did not know how to use the pain plan,
one said they use it when they cannot play, and three (50%) said they use it when an adult tells
them to. For the free text question asking about what helps their child’s pain feel better, 64% said
they use Tylenol (or another pain medication on the plan) and hot packs to help. Responses to the
fourth question regarding one thing about the pain plan that does not help with their child's
pain included feedback about: adjusting formatting of the plan, including a place for the
parent/patient to write notes, what to do if the pain does not go away, what to do during sports,
and what to do if a fever does not go away.
We compared the number of ED and inpatient hospital admissions (IHA) for each patient
pre and post pain plan implementation using the McNemar test and found that ED visits
decreased from pre (29 of 74 patients) to post (16 of 74 patients) X2(73) =12.85, p = .00034.
Similarly, the number of IHA decreased from 20 pre (LOS = 5.03 days) to 10 post (LOS = 4.69
days), X2(73) =28.89, p < .0001.
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In the pre pain plan time frame, patients who utilized the ED, 16 had more than one visit,
with one patient having eleven visits and another having nine. In the post pain plan time frame,
the patients who utilized ED, eight had more than one visit, with one patient having five visits
and five patients having three visits each. In the pre pain plan time frame, of the patients who had
IHAs, eight had more than one hospitalization, with one patient having eight hospitalizations and
another had four. In the post pain plan time frame, of the patients who had IHAs, three had two
hospitalizations, see Table 3. Pre and Post Implementation ED Visits and Inpatient
Hospitalizations.

Table 3. Pre and Post Implementation ED Visits and Inpatient Hospitalizations
Number of ED Visits or IHAs
1
2
3
4
5
6
7
8
9
10
11
Total ED Visits or IHAs

Pre Plan ED Visits

Post Plan ED Visits

Pre Plan IHAs

13
3
9
1

8
2
5

12
4
2
1

Post Plan IHAs
7
3

1
1
1
1
73

32

38
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Discussion
The primary aim of this project focused on the evaluation of the physical and
psychosocial risk factors related to pain experiences following the implementation of the
individualized pain plan. The individualized pain plans received positive feedback from both
parents and patients. The surveys were created with the goal of ease of readability and were
ensured to be understood by the families. The project members met with these families in person
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and administered surveys, which added a benefit to being able to get to know the patients and
families and gauge the overall feeling of the pain plans.
The purpose of this project is to evaluate the effectiveness of individualized pain plans
for a population of children diagnosed with SCD and their families. When comparing responses
from the patient and parent(s), there was a high rate of satisfaction with the pain plans from the
patient perspective, six patients were age appropriate, with over 83% response rate of mostly
satisfied (the pain plan helps for most of the day) and very satisfied (it helps all day). When
evaluating responses from patients for the PPST survey, the four teenage patients had a score
range of 3 to 5 and of the six non-teenage patients, four had a score from 0 to 2, and two had a
score of 4 to 5. All four of the teenage patients and two of the non-teenage patients fell into the
medium risk category, meaning this group may require additional education with the application
and use or reference to the individualized pain plan and help with coping with their pain, and
may be transitioning from the more acute pain experience to more chronic pain experiences. A
further evaluation of some that may be borderline high-risk may need additional interdisciplinary
services, such as psychology and social work. The four non-teenage patients are low risk and
may need more education on the pain plan as needed.
Interpretation
This project is meant to be used as an introduction and opening a door to approaching
pediatric sickle cell pain and management in an innovative way from the perspective of the
quality of life of the child and family. The goal of this project was to also help create a sense of
autonomy for the patients, especially those who are going into their teen years, to be able to take
an active role in their care and feel included in the decisions regarding treatment of their pain
symptoms, and to create a home pain management plan that is easy to use. We believe this
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project can have a significant impact on monitoring a patient and his/her family’s quality of life
and satisfaction with their ability to treat the symptoms as soon as they start. Additionally, this
method can be used across multiple chronic disease management therapies.
There is no comparison to other studies as this type of study has not been done before.
There were no costs involved in the development and implementation of this project.
Next steps
There is a lack of research for pediatric sickle cell pain crisis related to pain plans used in
the home setting. This proposal for the use of home pain plans is a new and innovative concept.
Next steps after the completion of this project include recommendations for the clinic to continue
to collect data by survey administration using the format of this study. There may be more
significance found over a longer period and/or a larger population size. It is also recommended
by the group to ensure understanding and complete a review of individualized pain plan as part
of discharge instructions from clinic for each visit. It was found on more than one occurrence
that the patient was unaware of the pain plan that was created for them, H/O staff will continue
to refer to the pain plan and educate on the importance of its use. We also recommended a
modification to the outline of the pain plan to allow for a patient and parent comment section to
record incidents of using the plan and what was done, which can be used for reference for the
parent and the provider. We encouraged the H/O team to consider making this plan digital so
parents and patients could access it on their phones and limit the risk of losing.
Limitations
During this study, there were no unintended consequences associated with the
intervention that were found. The authors of this paper found no missing data but did realize
some of the limitations of the study that had led to incomplete data collection. Many patients fell
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outside of the age range appropriate for the PPST and could not be evaluated.
Caregiver/parent/legal guardian satisfaction surveys were still obtained regardless of whether the
patient fit the study parameters. Additionally, there was a high rate of “no-show”
appointments, and reschedules which limited the sample size considerably, by approximately
sixty percent.
Conclusions
This project brought to light multiple variables regarding home pain management along
with pain and psychosocial evaluation in a clinic visit setting. This project would be very
sustainable to continue to collect further data as there is no cost to the clinic and because of its
simplistic design. This topic lacks research evidence for the individualized pain plans as these
sickle cell pain plans are unique to this hospital and were implemented less than two years ago.
The goal of this study is to provide evidence to other pediatric hospitals so that they can adopt
the use of the pain plans for their SCD patients. The next steps with the sickle cell pain plans
would be to work with clinic providers and nurses to make modifications to the structure of the
plan to make them as user friendly as possible. After reviewing results from the study, it would
be recommended that the clinic continue to collect data indefinitely due to the small sample
population of this study as this could provide stronger evidence for the use of the individualized
pain plans.
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